# Option Care Health, Inc.: financial statements, quarterly

OPCH · Nasdaq · CIK 1014739 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/opch.md) · [Financials](/companies/opch/financials.md) · [Filings](/companies/opch/filings.md) · [Insiders](/companies/opch/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/opch/financials.md?period=annual).

## Income statement

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,069](/filings/0001014739-24-000035.md) | [1,093](/filings/0001014739-24-000052.md) | [1,124 d](/filings/0001014739-26-000008.md) | [1,146](/filings/0001014739-24-000022.md) | [1,227](/filings/0001014739-25-000037.md) | [1,279](/filings/0001014739-25-000046.md) | [1,346 d](/filings/0001014739-26-000008.md) | [1,333](/filings/0001014739-26-000011.md) | [1,416](/filings/0001014739-25-000037.md) | [1,435](/filings/0001014739-25-000046.md) | [1,465 d](/filings/0001014739-26-000008.md) | [1,351](/filings/0001014739-26-000011.md) |
| Cost of revenue | $m | [818](/filings/0001014739-24-000035.md) | [839](/filings/0001014739-24-000052.md) | [369 d](/filings/0001014739-25-000012.md) | [908](/filings/0001014739-25-000022.md) | [978](/filings/0001014739-25-000037.md) | [1,022](/filings/0001014739-25-000046.md) | [540 d](/filings/0001014739-25-000012.md) | [1,070](/filings/0001014739-26-000011.md) | [1,147](/filings/0001014739-25-000037.md) | [1,162](/filings/0001014739-25-000046.md) | [1,183 d](/filings/0001014739-26-000008.md) | [1,089](/filings/0001014739-26-000011.md) |
| Gross profit | $m | [251](/filings/0001014739-24-000035.md) | [254](/filings/0001014739-24-000052.md) | [247 d](/filings/0001014739-26-000008.md) | [239](/filings/0001014739-25-000022.md) | [249](/filings/0001014739-25-000037.md) | [257](/filings/0001014739-25-000046.md) | [268 d](/filings/0001014739-26-000008.md) | [263](/filings/0001014739-26-000011.md) | [269](/filings/0001014739-25-000037.md) | [273](/filings/0001014739-25-000046.md) | [283 d](/filings/0001014739-26-000008.md) | [262](/filings/0001014739-26-000011.md) |
| Selling, general and administrative | $m | [154](/filings/0001014739-24-000035.md) | [158](/filings/0001014739-24-000052.md) | [148 d](/filings/0001014739-26-000008.md) | [155](/filings/0001014739-25-000022.md) | [154](/filings/0001014739-25-000037.md) | [157](/filings/0001014739-25-000046.md) | [165 d](/filings/0001014739-26-000008.md) | [168](/filings/0001014739-26-000011.md) | [170](/filings/0001014739-25-000037.md) | [172](/filings/0001014739-25-000046.md) | [172 d](/filings/0001014739-26-000008.md) | [175](/filings/0001014739-26-000011.md) |
| Operating income | $m | [82.4](/filings/0001014739-24-000035.md) | [81.0](/filings/0001014739-24-000052.md) | [84.6 d](/filings/0001014739-26-000008.md) | [69.0](/filings/0001014739-25-000022.md) | [80.7](/filings/0001014739-25-000037.md) | [85.1](/filings/0001014739-25-000046.md) | [87.0 d](/filings/0001014739-26-000008.md) | [79.2](/filings/0001014739-26-000011.md) | [82.7](/filings/0001014739-25-000037.md) | [84.5](/filings/0001014739-25-000046.md) | [91.5 d](/filings/0001014739-26-000008.md) | [72.5](/filings/0001014739-26-000011.md) |
| Interest expense | $m | [13.2](/filings/0001014739-24-000035.md) | [11.8](/filings/0001014739-24-000052.md) | [12.4 d](/filings/0001014739-24-000009.md) | [13.2](/filings/0001014739-24-000022.md) | [12.6](/filings/0001014739-25-000037.md) | [12.3](/filings/0001014739-24-000052.md) | [10.9 d](/filings/0001014739-26-000008.md) | [13.2](/filings/0001014739-26-000011.md) | [14.4](/filings/0001014739-25-000037.md) | [14.1](/filings/0001014739-25-000046.md) | [12.7 d](/filings/0001014739-26-000008.md) | [13.3](/filings/0001014739-26-000011.md) |
| Income tax | $m | [41.1](/filings/0001014739-24-000035.md) | [13.8](/filings/0001014739-24-000052.md) | [21.7 d](/filings/0001014739-26-000008.md) | [12.2](/filings/0001014739-25-000022.md) | [19.0](/filings/0001014739-25-000037.md) | [19.7](/filings/0001014739-25-000046.md) | [20.9 d](/filings/0001014739-26-000008.md) | [16.8](/filings/0001014739-26-000011.md) | [18.3](/filings/0001014739-25-000037.md) | [17.2](/filings/0001014739-25-000046.md) | [23.0 d](/filings/0001014739-26-000008.md) | [15.7](/filings/0001014739-26-000011.md) |
| Net income | $m | [114](/filings/0001014739-24-000052.md) | [56.3](/filings/0001014739-24-000052.md) | [57.2 d](/filings/0001014739-26-000008.md) | [44.8](/filings/0001014739-25-000046.md) | [53.0](/filings/0001014739-25-000046.md) | [53.9](/filings/0001014739-25-000046.md) | [60.1 d](/filings/0001014739-26-000008.md) | [46.7](/filings/0001014739-26-000011.md) | [50.5](/filings/0001014739-25-000046.md) | [51.8](/filings/0001014739-25-000046.md) | [58.5 d](/filings/0001014739-26-000008.md) | [45.3](/filings/0001014739-26-000011.md) |
| Diluted EPS | $ per share | [0.63](/filings/0001014739-24-000035.md) | [0.31](/filings/0001014739-24-000052.md) | not reported | [0.26](/filings/0001014739-25-000022.md) | [0.30](/filings/0001014739-25-000037.md) | [0.31](/filings/0001014739-25-000046.md) | not reported | [0.28](/filings/0001014739-26-000011.md) | [0.31](/filings/0001014739-25-000037.md) | [0.32](/filings/0001014739-25-000046.md) | not reported | [0.29](/filings/0001014739-26-000011.md) |
| Basic EPS | $ per share | [0.64](/filings/0001014739-24-000035.md) | [0.31](/filings/0001014739-24-000052.md) | not reported | [0.26](/filings/0001014739-25-000022.md) | [0.31](/filings/0001014739-25-000037.md) | [0.32](/filings/0001014739-25-000046.md) | not reported | [0.28](/filings/0001014739-26-000011.md) | [0.31](/filings/0001014739-25-000037.md) | [0.32](/filings/0001014739-25-000046.md) | not reported | [0.29](/filings/0001014739-26-000011.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold, us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [441](/filings/0001014739-23-000034.md) | [386](/filings/0001014739-23-000042.md) | [344](/filings/0001014739-25-000012.md) | [220](/filings/0001014739-24-000022.md) | [377](/filings/0001014739-24-000035.md) | [483](/filings/0001014739-24-000052.md) | [413](/filings/0001014739-26-000008.md) | [171](/filings/0001014739-25-000022.md) | [199](/filings/0001014739-25-000037.md) | [310](/filings/0001014739-25-000046.md) | [233](/filings/0001014739-26-000011.md) | [177](/filings/0001014739-26-000011.md) |
| Current assets | $m | [1,198](/filings/0001014739-23-000034.md) | [1,116](/filings/0001014739-23-000042.md) | [1,094](/filings/0001014739-25-000012.md) | [1,130](/filings/0001014739-24-000022.md) | [1,227](/filings/0001014739-24-000035.md) | [1,321](/filings/0001014739-24-000052.md) | [1,323](/filings/0001014739-26-000008.md) | [1,099](/filings/0001014739-25-000022.md) | [1,175](/filings/0001014739-25-000037.md) | [1,283](/filings/0001014739-25-000046.md) | [1,265](/filings/0001014739-26-000011.md) | [1,195](/filings/0001014739-26-000011.md) |
| Total assets | $m | [3,321](/filings/0001014739-23-000034.md) | [3,244](/filings/0001014739-23-000042.md) | [3,217](/filings/0001014739-25-000012.md) | [3,250](/filings/0001014739-24-000022.md) | [3,349](/filings/0001014739-24-000035.md) | [3,428](/filings/0001014739-24-000052.md) | [3,422](/filings/0001014739-26-000008.md) | [3,309](/filings/0001014739-25-000022.md) | [3,383](/filings/0001014739-25-000037.md) | [3,480](/filings/0001014739-25-000046.md) | [3,456](/filings/0001014739-26-000011.md) | [3,380](/filings/0001014739-26-000011.md) |
| Current liabilities | $m | [668](/filings/0001014739-23-000034.md) | [624](/filings/0001014739-23-000042.md) | [618](/filings/0001014739-25-000012.md) | [637](/filings/0001014739-24-000022.md) | [695](/filings/0001014739-24-000035.md) | [763](/filings/0001014739-24-000052.md) | [780](/filings/0001014739-26-000008.md) | [714](/filings/0001014739-25-000022.md) | [774](/filings/0001014739-25-000037.md) | [824](/filings/0001014739-25-000046.md) | [829](/filings/0001014739-26-000011.md) | [730](/filings/0001014739-26-000011.md) |
| Total liabilities | $m | [1,846](/filings/0001014739-23-000034.md) | [1,804](/filings/0001014739-23-000042.md) | [1,795](/filings/0001014739-25-000012.md) | [1,820](/filings/0001014739-24-000022.md) | [1,937](/filings/0001014739-24-000035.md) | [2,001](/filings/0001014739-24-000052.md) | [2,018](/filings/0001014739-26-000008.md) | [1,958](/filings/0001014739-25-000022.md) | [2,023](/filings/0001014739-25-000037.md) | [2,121](/filings/0001014739-25-000046.md) | [2,129](/filings/0001014739-26-000011.md) | [2,029](/filings/0001014739-26-000011.md) |
| Long-term debt | $m | [1,057](/filings/0001014739-23-000034.md) | [1,057](/filings/0001014739-23-000042.md) | [1,057](/filings/0001014739-25-000012.md) | [1,056](/filings/0001014739-24-000022.md) | [1,106](/filings/0001014739-24-000035.md) | [1,105](/filings/0001014739-24-000052.md) | [1,105](/filings/0001014739-26-000008.md) | [1,104](/filings/0001014739-25-000022.md) | [1,104](/filings/0001014739-25-000037.md) | [1,155](/filings/0001014739-25-000046.md) | [1,154](/filings/0001014739-26-000011.md) | [1,153](/filings/0001014739-26-000011.md) |
| Current portion of debt | $m | [6.0](/filings/0001014739-23-000034.md) | [6.0](/filings/0001014739-23-000042.md) | [6.0](/filings/0001014739-25-000012.md) | [6.0](/filings/0001014739-24-000022.md) | [6.5](/filings/0001014739-24-000035.md) | [6.5](/filings/0001014739-24-000052.md) | [6.5](/filings/0001014739-26-000008.md) | [6.5](/filings/0001014739-25-000022.md) | [6.5](/filings/0001014739-25-000037.md) | [6.8](/filings/0001014739-25-000046.md) | [6.8](/filings/0001014739-26-000011.md) | [6.8](/filings/0001014739-26-000011.md) |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [1,475](/filings/0001014739-24-000052.md) | [1,440](/filings/0001014739-24-000052.md) | [1,422](/filings/0001014739-26-000008.md) | [1,429](/filings/0001014739-25-000046.md) | [1,411](/filings/0001014739-25-000046.md) | [1,426](/filings/0001014739-25-000046.md) | [1,404](/filings/0001014739-26-000011.md) | [1,351](/filings/0001014739-26-000011.md) | [1,360](/filings/0001014739-25-000046.md) | [1,359](/filings/0001014739-25-000046.md) | [1,326](/filings/0001014739-26-000011.md) | [1,351](/filings/0001014739-26-000011.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [170 d](/filings/0001014739-24-000035.md) | [61.0 d](/filings/0001014739-24-000052.md) | [51.0 d](/filings/0001014739-26-000008.md) | [(68.8)](/filings/0001014739-25-000022.md) | [196 d](/filings/0001014739-25-000037.md) | [160 d](/filings/0001014739-25-000046.md) | [36.1 d](/filings/0001014739-26-000008.md) | [(7.2)](/filings/0001014739-26-000011.md) | [90.3 d](/filings/0001014739-25-000037.md) | [139 d](/filings/0001014739-25-000046.md) | [35.9 d](/filings/0001014739-26-000008.md) | [(12.1)](/filings/0001014739-26-000011.md) |
| Capital expenditure | $m | [7.8 d](/filings/0001014739-24-000035.md) | [8.4 d](/filings/0001014739-24-000052.md) | [19.9 d](/filings/0001014739-26-000008.md) | [5.8](/filings/0001014739-25-000022.md) | [9.8 d](/filings/0001014739-25-000037.md) | [9.7 d](/filings/0001014739-25-000046.md) | [10.3 d](/filings/0001014739-26-000008.md) | [9.4](/filings/0001014739-26-000011.md) | [9.1 d](/filings/0001014739-25-000037.md) | [9.2 d](/filings/0001014739-25-000046.md) | [13.6 d](/filings/0001014739-26-000008.md) | [9.0](/filings/0001014739-26-000011.md) |
| Share repurchases | $m | [0.0 d](/filings/0001014739-24-000035.md) | [100 d](/filings/0001014739-24-000052.md) | [75.2 d](/filings/0001014739-26-000008.md) | [40.1](/filings/0001014739-24-000022.md) | [78.1 d](/filings/0001014739-25-000037.md) | [42.0 d](/filings/0001014739-25-000046.md) | [92.6 d](/filings/0001014739-26-000008.md) | not reported | not reported | [62.5 d](/filings/0001014739-25-000046.md) | [95.1 d](/filings/0001014739-26-000008.md) | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q2 FY2022 (2022-06-30) | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [182](/filings/0001014739-23-000034.md) | [183](/filings/0001014739-23-000042.md) | [183](/filings/0001014739-24-000022.md) | [181](/filings/0001014739-24-000035.md) | [181](/filings/0001014739-24-000052.md) | [176](/filings/0001014739-25-000022.md) | [174](/filings/0001014739-25-000037.md) | [172](/filings/0001014739-25-000046.md) | [167](/filings/0001014739-26-000011.md) | [164](/filings/0001014739-25-000037.md) | [163](/filings/0001014739-25-000046.md) | [158](/filings/0001014739-26-000011.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 157,027,504 at 2026-04-28, from the cover of the [10-Q filed 2026-04-30](/filings/0001014739-26-000011.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:30 ET. No prices; not investment advice.